[1] ELTZSCHIG HK.ECKLE T.Ischemia and reperfusion——from mechanism to translation[J].Nat Med, 2011, 17(11):1391. doi: 10.1038/nm.2507
[2] HODZIC Z, SCHILL E M, BOLOCK AM, et al.IL-33 and the intestine:The good, the bad, and the inflammatory[J].Cytokine, 2017, 100:1. doi: 10.1016/j.cyto.2017.06.017
[3] DRAKE LY, KITA H.IL-33:biological properties, functions, and roles in airway disease[J].Immunol Rev, 2017, 278(1):173.
[4] ZHU P, DUAN L, CHEN J, et al.Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice[J].Hum Gene Ther, 2011, 22(7):853. doi: 10.1089/hum.2010.145
[5] CHEN J, DUAN L, XIONG A, et al.Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-gamma production in mice[J].J Mol Med (Berl), 2012, 90(12):1505. doi: 10.1007/s00109-012-0938-4
[6] FREITAS MC, UCHIDA Y, ZHAO D, et al.Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion[J].Liver Transpl, 2010, 16(9):600.
[7] MASUDA T, IWASHITA Y, HAGIWARA S, et al.Dihydrolipoyl histidinate zinc complex, a new antioxidant, attenuates hepatic ischemia-reperfusion injury in rats[J].J Gastroenterol Hepatol, 2011, 26(11):1652. doi: 10.1111/jgh.2011.26.issue-11
[8] DUAN L, CHEN J, ZHANG H, et al.Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3(+) regulatory T-cell responses in mice[J].Mol Med, 2012, 18(18):753.
[9] CAYROL C, GIRARD JP.The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1[J].Proc Natl Acad Sci U S A, 2009, 106(22):9021. doi: 10.1073/pnas.0812690106
[10] TALABOT-AYER D, LAMACCHIA C, GABAY C, et al.Interleukin-33 is biologically active independently of caspase-1 cleavage[J].J Biol Chem, 2009, 284(29):19420. doi: 10.1074/jbc.M901744200
[11] LUTHI AU, CULLEN SP, MCNEELA EA, et al.Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases[J].Immunity, 2009, 31(1):84. doi: 10.1016/j.immuni.2009.05.007
[12] SEKI K, SANADA S, KUDINOVA AY, et al.Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling[J].Circ Heart Fail, 2009, 2(6):684. doi: 10.1161/CIRCHEARTFAILURE.109.873240
[13] SAKAI N, VAN SWERINGEN HL, QUILLIN RC, et al.Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice[J].Hepatology, 2012, 56(4):1468. doi: 10.1002/hep.v56.4
[14] LUO Y, ZHOU YQ, XIAO W, et al.Interleukin-33 ameliorates ischemic brain injury in experimental stroke through promoting Th2 response and suppressing Th17 response[J].Brain Res, 2015, 9(1597):86.
[15] KONO H, FUJⅡ H, OGIKU M, et al.Role of IL-17A in neutrophil recruitment and hepatic injury after warm ischemia-reperfusion mice[J].J Immunol, 2011, 187(9):4818. doi: 10.4049/jimmunol.1100490
[16] AKCAY A, NGUYEN Q, HE Z, et al.IL-33 exacerbates acute kidney injury[J].J Am Soc Nephrol, 2011, 22(11):2057. doi: 10.1681/ASN.2010091011
[17] DUAN L, WANG CY, CHEN J, et al.High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response[J].Lab Invest, 2011, 91(1):43.